Mori, M.; Fujioka, T.; Kubota, K.; Katsuta, L.; Yashima, Y.; Nomura, K.; Yamaga, E.; Tsuchiya, J.; Hosoya, T.; Oda, G.;
et al. Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. J. Clin. Med. 2021, 10, 3173.
https://doi.org/10.3390/jcm10143173
AMA Style
Mori M, Fujioka T, Kubota K, Katsuta L, Yashima Y, Nomura K, Yamaga E, Tsuchiya J, Hosoya T, Oda G,
et al. Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Journal of Clinical Medicine. 2021; 10(14):3173.
https://doi.org/10.3390/jcm10143173
Chicago/Turabian Style
Mori, Mio, Tomoyuki Fujioka, Kazunori Kubota, Leona Katsuta, Yuka Yashima, Kyoko Nomura, Emi Yamaga, Junichi Tsuchiya, Tokuko Hosoya, Goshi Oda,
and et al. 2021. "Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography" Journal of Clinical Medicine 10, no. 14: 3173.
https://doi.org/10.3390/jcm10143173
APA Style
Mori, M., Fujioka, T., Kubota, K., Katsuta, L., Yashima, Y., Nomura, K., Yamaga, E., Tsuchiya, J., Hosoya, T., Oda, G., Nakagawa, T., Onishi, I., & Tateishi, U.
(2021). Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Journal of Clinical Medicine, 10(14), 3173.
https://doi.org/10.3390/jcm10143173
